| Gilead Sciences Switzerland Sàrl - Vemlidy, Filmtabletten | | 66190 | | 01 | | Vemlidy | | Filmtabletten | | J05AF | | Nucleoside and Nucleotide Reverse Transcriptase Inhibitors | | 13.07.2017 | | |
| | Composition | | tenofovirum alafenamidum 25 mg ut tenofoviri alafenamidi hemifumaras, lactosum monohydricum 94.96 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 1.331 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Tenofovirum Alafenamidum | 25 mg |
| | BAG: Active Agent | Dose |
|---|
| Tenofovirum Alafenamidum | 25 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Lactose Monohydrate | 94.96 mg | | | Macrogol | | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 449.12 | 504.85 | A | SL | No |
|
|
